Very impressive results for a new type of gene therapy.
ZIOPHARM Announces Clinical Data on Ad-RTS-hIL-12 Demonstrates Survival Benefits in Patients with Recurrent Brain Cancer
pipelinereview.com/index.php/2016111763002/DNA-RNA-and-Cells/ZIOPHARM-Announces-Clinical-Data-on-Ad-RTS-hIL-12-Demonstrates-Survival-Benefits-in-Patients-with-Recurrent-Brain-Cancer.html